Home » Topics » Conferences

Conferences
RSS

Glaxo Wellcome/BioChem Pharma antitumor agent described at 211th ACS

April 19, 1996

YM-47813 revealed at 211th ACS

April 19, 1996

SNAP-5399 presented at 211th ACS

April 19, 1996

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

SD-998, thrombin inhibitor

April 19, 1996

Yamanouchi selects YM-471 for clinical development

April 19, 1996

New ETA antagonist from SmithKline Beecham: SB-225757

April 19, 1996

EMD-94246, promising endothelin antagonist for hypertension

April 19, 1996

CMI-568, dual PAF antagonist and 5-LO inhibitor from CytoMed

April 19, 1996

Combined thrombolytic/neuroprotective agents more effective in treating stroke

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...